Why the study?
Do therapeutic doses of tricyclic or tetracyclic antidepressants affect cardiovascular parameters in patients?
Do therapeutic doses of tricyclic or tetracyclic antidepressants affect cardiovascular parameters in patients?
Therapeutic doses of tricyclic and tetracyclic antidepressants cause reversible ECG changes and a decrease in myocardial contractility, with only increased heart rate persisting after 13 months of therapy.
Answers are grounded in this paper and cite their sources.
Supports ECG monitoring at tricyclic initiation; hypothesis-generating for contractility effects and long-term outcomes.
Cardiovascular effects of therapeutic doses of tricyclic or tetracyclic antidepressants (TCA) were examined in 66 patients. After three weeks of therapy, heart rate and PR interval were increased (P less than .02, P less than .05), while prolongation of the QTc time and the QRS interval did not reach significant levels. We observed significant flattening of T waves (P less than .05), which was not associated with changes in the serum potassium level. These changes were reversible after treatment was discontinued. When therapy was maintained for 13 months, only the heart rate continued to be increased, whereas all other ECG values had returned to normal. The TCA therapy led to a significant prolongation of the preejection period (P less than .01) and slight shortening of the left ventricular ejection time, indicating a decrease in myocardial contractility. There was no difference of effects on the values studied between tricyclic and tetracyclic antidepressants.
No takes yet. Share an insight, caveat, or question.
D Burckhardt (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: